Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis
Open Access
- 1 September 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (5) , 1794-1800
- https://doi.org/10.1182/blood-2005-01-0346
Abstract
Honokiol (HNK) is an active component purified from magnolia, a plant used in traditional Chinese and Japanese medicine. Here we show that HNK signifThis publication has 54 references indexed in Scilit:
- Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological ActivityMayo Clinic Proceedings, 2004
- Serine protease inhibitor 2A inhibits caspase‐independent cell deathFEBS Letters, 2004
- Apoptosis-inducing factor (AIF): caspase-independent after allCell Death & Differentiation, 2004
- A serine protease is involved in the initiation of DNA damage-induced apoptosisCell Death & Differentiation, 2003
- Caspase-independent cell death in T lymphocytesNature Immunology, 2003
- Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341Blood, 2003
- Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaBlood, 2002
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cellsLife Sciences, 1994
- Effective Inhibition of Hydroxyl Radicals by Hydroxylated Biphenyl CompoundsFree Radical Research Communications, 1993